Log in or Sign up for Free to view tailored content for your specialty!
Glaucoma News
Researchers identify factors associated with severe vision loss in neovascular glaucoma
The progression of vision loss among patients with neovascular glaucoma appeared linked to factors such as the disease stage at diagnosis, age, sex, a history of type 2 diabetes and insurance status, according to study results.
ChatGPT accurately, satisfactorily answers most glaucoma-related questions
ChatGPT correctly and satisfactorily answered nine out of 10 frequently asked questions about glaucoma concerning general information, diagnosis, treatment and prevention, according to an analysis published in Journal of Glaucoma.
Log in or Sign up for Free to view tailored content for your specialty!
Laser training program enables optometrist-delivered glaucoma treatment in UK
An educational training program in the U.K. enabled non-MD ophthalmic practitioners to safely and effectively deliver selective laser trabeculoplasty to patients with glaucoma, according to a study published in Eye.
Nearly 40% of children with glaucoma do not undergo yearly visual field testing
While most children with glaucoma have at least one visual field test per year, Black and multiracial children were among those with significantly lower testing frequency, according to a single-center study published in Journal of Glaucoma.
VIDEO: Minimal IOP changes seen with aflibercept 8 mg or 2 mg at 48 weeks
In this Healio Video Perspective from the ASRS meeting, Jordana G. Fein, MD, MS, of Retina Group of Washington discusses IOP outcomes in patients with diabetic macular edema who were treated with aflibercept 8 mg or aflibercept 2 mg.
Researchers identify 18 drugs associated with angle-closure glaucoma
Eighteen medications appeared to be associated with angle-closure glaucoma, including sulfonamides, serotonergic agents and antimuscarinic agents, according to a retrospective analysis published in Ophthalmology Glaucoma.
De novo classification of ocular pressure pump tops recent glaucoma headlines
Healio’s recent stories in glaucoma include the de novo classification of an ocular pressure adjusting pump and promising results with timolol microdrops to lower IOP.
Alcon acquires Belkin Vision, direct selective laser trabeculoplasty device
Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty technology, according to a press release.
BLOG: Considerations for expanding the scope of optometry
As a past president of the Pennsylvania Optometric Association, I am very familiar with how our profession expands its scope of practice.
FDA grants de novo classification to Fysx ocular pressure adjusting pump
The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with normal-tension glaucoma or open-angle glaucoma with IOP of 21 mm Hg or less, according to a press release from Balance Ophthalmics.
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read